Serum Albumin in Acute Coronary Syndrome

NCT06727084 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-07-04

No results posted yet for this study

Summary

Our study aims to investigate the predictive value of serum albumin and short-term mortality in patients with Acute Coronary Syndrome (ACS)

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Osama A Arafa, Professor · Faculty of Medicine Sohag University

  • Hamdy S Mohamed, A .Professor · Faculty of Medicine Sohag University

  • Ahmed E Ebrahim, Lecturer · Faculty of Medicine Sohag University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-04-01
Completion
2026-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727084 on ClinicalTrials.gov